These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 13756083)

  • 41. [Action of carbaminoyl-beta-methylcholine on constipation due to dystonia of the colon].
    SALMON-MALEBRANCHE AR
    Sem Hop; 1951 Sep; 27(72):2836-7. PubMed ID: 14883904
    [No Abstract]   [Full Text] [Related]  

  • 42. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.
    Bajor A; Törnblom H; Rudling M; Ung KA; Simrén M
    Gut; 2015 Jan; 64(1):84-92. PubMed ID: 24727487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dioctyl sodium sulfosuccinate- an ineffective prophylactic laxative.
    Goodman J; Pang J; Bessman AN
    J Chronic Dis; 1976 Jan; 29(1):59-63. PubMed ID: 1254685
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oral dioctyl sodium sulfosuccinate on intake-output studies of human small and large intestine.
    Chapman RW; Sillery J; Fontana DD; Matthys C; Saunders DR
    Gastroenterology; 1985 Sep; 89(3):489-93. PubMed ID: 2410320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of bile acids in the pathogenesis of chronic diarrhea].
    Krums LM; Gubina AV; Parfenov AI; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2012; (3):35-9. PubMed ID: 22830222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.
    Tack J; Middleton SJ; Horne MC; Piessevaux H; Bloor JS; Meyers NL; Palmer RM
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1655-65. PubMed ID: 16696817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Faecal bile acids and the irritable colon syndrome.
    Flynn M; Hammond P; Darby C; Hyland J; Taylor I
    Digestion; 1981; 22(3):144-9. PubMed ID: 7286462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New fecal softener (doxinate) in the treatment of constipation.
    SPIESMAN MG; MALOW L
    J Lancet; 1956 Jun; 76(6):164-7. PubMed ID: 13319919
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical trials of treatment of chronic constipation with a surface-active and hydrotropic agent in oral administration (dioctyl sodium sulfosuccinate with danthron). 64 cases, 41 of these assembled in a table].
    Dissard MP
    Lyon Med; 1968 Jun; 219(26):2127-42. PubMed ID: 5742457
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)].
    Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
    Semergen; 2017; 43(1):43-56. PubMed ID: 27810257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of dioctyl sodium sulfosuccinate on structure and function of rodent and human intestine.
    Saunders DR; Sillery J; Rachmilewitz D
    Gastroenterology; 1975 Aug; 69(2):380-6. PubMed ID: 1150046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients.
    Hofmann AF; Loening-Baucke V; Lavine JE; Hagey LR; Steinbach JH; Packard CA; Griffin TL; Chatfield DA
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):598-606. PubMed ID: 18955863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
    Semergen; 2017 Mar; 43(2):123-140. PubMed ID: 28189496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difficult defecation in constipated patients and its relationship to colonic disorders.
    Bouchoucha M; Devroede G; Bon C; Mary F; Bejou B; Benamouzig R
    Int J Colorectal Dis; 2016 Mar; 31(3):685-91. PubMed ID: 26861636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concept and treatment of the intestinal distress syndrome.
    SOBEL IJ
    Clin Med (Northfield); 1962 Aug; 69():1814-8. PubMed ID: 15445877
    [No Abstract]   [Full Text] [Related]  

  • 58. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.
    Ford AC; Moayyedi P; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Quigley EM;
    Am J Gastroenterol; 2014 Aug; 109 Suppl 1():S2-26; quiz S27. PubMed ID: 25091148
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of dioctyl sodium sulfosuccinate on colonic fluid and electrolyte movement.
    Donowitz M; Binder HJ
    Gastroenterology; 1975 Oct; 69(4):941-50. PubMed ID: 170157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The irritable colon syndrome].
    ABBONA C; GATO E; RAFFETTO A
    Arch Maragliano Patol Clin; 1961 Dec; 17():1335-48. PubMed ID: 13858817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.